The characterization and isolation of various stem cell populations, from embryonic to tissue-derived stem cells and induced pluripotent stem cells (iPSCs), have led to a rapid growth in the field of stem cell researc...The characterization and isolation of various stem cell populations, from embryonic to tissue-derived stem cells and induced pluripotent stem cells (iPSCs), have led to a rapid growth in the field of stem cell research and its potentially clinical application in the field of regenerative medicine and tissue repair. Stem cell therapy has recently progressed from the preclinical to the early clinical trial arena for a variety of diseases states, although further knowledge on action mechanisms, long-term safety issues, and standardization and characterization of the therapeutic cell products remains to be thoroughly elucidated. In this paper we summarize the current state of the art of basic and clinical research that were highlighted at the 2012 meeting of the Spanish Cell Therapy Network. This includes the current research involving in genomic and transcriptomic characterization of selected stem cell populations, studies of the role of resident and transplanted stem cells during tissue regeneration and their mechanism of action, improved new strategies of tissue engineering, transplantation of mesenchymal stem cells (MSCs) in different animal models of disease, disease correction by iPSCs, and preliminary results of cell therapy in human clinical trials.展开更多
基金supported by grants from the Ministry of Economy and Competitiveness(FIS PI10/02529,FIS EC07/90762,FIS PI12/00760,FIS PI13/00666)the Ministry of Science and Technology(BIO2009-13903-C02-02)+4 种基金the Andalusian Government(P07-CVI-2781,PAIDI BIO-217,PI-0729-2010)Spanish Cell Therapy Network(TerCel)and CIBER-BBN are an initiative funded by the VI National R&D&I Plan 2008-2011(RD06/0010/0023,RD12/0019/0001)Advanced Therapies and Transplant General Direction(Health Ministry,Spain)(TRA-137),Iniciativa Ingenio 2010,Consolider Program,CIBER Actions,and financed by the Instituto de Salud Carlos Ⅲ(ISC-Ⅲ)with assistance from the European Regional Development FundWork in Munoz-Chapuli’s laboratory is supported by grants BFU2011-25304,BFU2012-35799,P11-CTS-7564,and PITN-GA-2011-289600in Raya’s laboratory by grants SAF2012-33526,ACI2010-1117,and ISC-Ⅲ(TerCel,RD12/0019/0019).
文摘The characterization and isolation of various stem cell populations, from embryonic to tissue-derived stem cells and induced pluripotent stem cells (iPSCs), have led to a rapid growth in the field of stem cell research and its potentially clinical application in the field of regenerative medicine and tissue repair. Stem cell therapy has recently progressed from the preclinical to the early clinical trial arena for a variety of diseases states, although further knowledge on action mechanisms, long-term safety issues, and standardization and characterization of the therapeutic cell products remains to be thoroughly elucidated. In this paper we summarize the current state of the art of basic and clinical research that were highlighted at the 2012 meeting of the Spanish Cell Therapy Network. This includes the current research involving in genomic and transcriptomic characterization of selected stem cell populations, studies of the role of resident and transplanted stem cells during tissue regeneration and their mechanism of action, improved new strategies of tissue engineering, transplantation of mesenchymal stem cells (MSCs) in different animal models of disease, disease correction by iPSCs, and preliminary results of cell therapy in human clinical trials.
